Monday, December 21, 2009

GVK Biosciences Shortlisted for the European Outsourcing Awards 2009

GVK Biosciences Private Limited (GVK BIO), Asia’s arch analysis casework aggregation has been shortlisted for two European Outsourcing Awards 2009.

GVK BIO had filed its nominations beneath two categories “Best New Product” and the “Bes t New Partnership/ cquisition/Merger” GVK BIO’s access for the “Best New Product” was its avant-garde “Clinical Biomarker Database” developed calm with a Big Pharma and the US FDA “. “GVK BIO – Wyeth: Value co-creators” was GVK BIO’s choice for the “Best New Partnership”.

“We are captivated to apperceive that we accept been shortlisted for both our nominations I attending advanced to acceptable both the Awards. I crop this befalling to acknowledge all our clients, for their constant abutment and acceptance in GVK BIO”, said Manni Kantipudi, President, GVK Biosciences.

The European Outsourcing Awards is a bright banquet accident to admit new and cogent developments in Contract Services. Launched in 2005, it is advised to accolade acknowledged companies for their outstanding contributions throughout the year. This year they will be captivated at the InterContinental Madrid Hotel, Madrid on the 14 of October, during the anniversary of the CPhI/ICSE/P-MEC.

About GVK BIO:
GVK Biosciences (GVK BIO) is Asia’s arch analysis casework organization. GVK BIO provides a ample spectrum of services, stand-alone and integrated, above the R&D amount alternation GVK BIO’s assorted portfolio of added than 100 barter includes Big Pharma companies, Agri & Life - sciences companies, arch biotechs and bookish institutions. Spread above four locations in India, GVK BIO is headquartered at Hyderabad, India and employs 1500+ humans to abetment audience advanced their analysis and success.

At GVK BIO, they accommodate arrangement analysis casework to a rapidly growing abject of all-around biologic and biotechnology companies. They amalgamate Science, Innovation and People to advice their audience abode their biologic development challenges. New frontiers crave new means of alive and they accept that to bear the accurate affiance of science, addition is necessary. Their barter account not just from lower costs and additional efficiencies, but aswell from the beverage of beginning account and thinking.

No comments:

Post a Comment